You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
四環醫藥(00460.HK):拒絕非法走私產品 倡導中國醫美「正能量」
阿思達克 08-11 15:01
對於國家衛健委牽頭八部委發布「關於印發打擊非法醫療美容服務專項整治工作方案的通知」,以及近日人民日報刊發的文章表明,要加強監管,嚴厲打擊非法醫療美容服務,營造風清氣正的醫美大環境。 四環醫藥(00460.HK)指,旗下北京渼顏空間生物醫藥作為進口注射用A型肉毒毒素樂提葆的中國總代理,在2020年10月從中國國家藥品監督管理局獲得該產品的正式批准,成為第一家韓國該類產品獲得批准的醫藥企業。作為中國醫美「正能量」的一份子,公司積極響應八部委「打擊非法醫療美容服務」專項活動,責無旁貸。 四環醫美指,非法渠道的所謂醫美產品,不僅侵害求美者的身心,而且嚴重阻礙了中國醫美健康持續發展之路,將積極主動配合相關政府職能部門,追根溯源,為嚴厲打擊非法產品走私,非法產品製售,非法產品運輸,提供有力證據。同時也會努力敦促韓國相關企業尊重和配合中國政府的政策、嚴格監管出口渠道、共同防範打擊走私,確保韓國醫美產品的合法性,保障兩國消費者的利益。 四環醫美又指,將積極與中國整形美容協會行業發展與自律委員會合作,積極參與「中國醫美」小程序,公布採購產品的合規醫美醫療機構名單,並定期更新,聯合推廣產品的「掃碼驗真」功能。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account